Page last updated: 2024-08-23

triamcinolone and Hyperoxia

triamcinolone has been researched along with Hyperoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, GJ; Choi, MY; Choi, WS; Chung, IY; Kang, SS; Kim, YH; Kim, YS; Lee, JH; Park, CH; Roh, GS; Yoo, JM	1

Other Studies

1 other study(ies) available for triamcinolone and Hyperoxia

Article	Year
Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia. Neurobiology of disease, 2007, Volume: 26, Issue:3 Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Body Weight; Cytokines; Disease Models, Animal; Encephalitis; Female; Gene Expression Regulation; Hyperoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Retinal Artery; Retinal Diseases; Signal Transduction; Triamcinolone; Vascular Endothelial Growth Factor A	2007

Article

Year

Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.

Neurobiology of disease, 2007, Volume: 26, Issue:3

Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Body Weight; Cytokines; Disease Models, Animal; Encephalitis; Female; Gene Expression Regulation; Hyperoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Retinal Artery; Retinal Diseases; Signal Transduction; Triamcinolone; Vascular Endothelial Growth Factor A

2007